<?xml version="1.0" encoding="UTF-8"?>
<ref id="B129-materials-13-04532">
 <label>129.</label>
 <element-citation publication-type="book">
  <person-group person-group-type="author">
   <name>
    <surname>Sashegyi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Felli</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Noel</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <source>Benefit-Risk Assessment in Pharmaceutical Research and Development</source>
  <series>Chapman and Hall/CRC Biostatistics Series</series>
  <publisher-name>CRC Press, Taylor and Francis Group</publisher-name>
  <publisher-loc>Boca Raton, FL, USA</publisher-loc>
  <year>2014</year>
  <volume>Volume 13</volume>
  <pub-id pub-id-type="doi">10.1002/pst.1627</pub-id>
 </element-citation>
</ref>
